Since B-cells facilitate the progression of MS (26), we predicted that the minor “A” rs630923 allele may play its protective role by creating a binding site for MEF2C that attenuates the transcription of CXCR5 gene encoding the critical chemotactic receptor on these cells. Here, CXCR5 is linked to myeloid sarcoma.